Treatment Innovations
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.
Fasting and Cancer: What Does The Science Say?
Fasting has been growing in popularity over the last few decades. This is no surprise considering that there have been several studies that link fasting to longevity.
Innovative molecular therapies target and disrupt uncontrollable growth of cancer cells
wo new studies represent a big step toward developing innovative molecular therapies capable of disrupting the uncontrollable growth of cancers at their roots.
It’s working!’ Columbus cancer center is first in Georgia to administer this new therapy
The treatment, Bi-Specific T-Cell Engager (BiTE) therapy, is showing promising results in U.S. patients with certain types of cancer, including small-cell lung cancer, lymphoma and multiple myeloma. BiTE therapy helps the immune system recognize cancer cells and destroy them.
Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer
The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive for grade group (GG) ≥2 prostate cancer and can improve the proportion of biopsies avoided.
100-year-old heart drug made from foxglove may help ‘dissolve’ clumps of spreading cancer cells
By breaking up clusters of cancer cells, an old heart drug called digoxin may help stop tumors from spreading to other organs, a small trial shows.
US firm brings new prostate cancer treatment to Hong Kong, cutting risks posed by surgery
An American medical technology firm has introduced a novel treatment in Hong Kong that uses electric pulses to kill prostate cancer cells while minimising the risks of incontinence and sexual dysfunction.
New cancer vaccine could prevent kidney cancer recurrence
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber Cancer Institute tested the vaccine in nine patients with stage III or IV clear cell renal cell carcinoma (a form of kidney cancer).
Efforts to improve cancer research must persist and intensify – opinion
The integration of new technologies and treatment paradigms into the country’s health system each year enhances patients’ quality of life and enables many to manage their illnesses more effectively.
Breast cancer treatment advances with light-activated ‘smart bomb’
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated metastatic breast cancer tumors.
Short-course radiation matches standard therapy for endometrial cancer
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher-dose vaginal brachytherapy for endometrial cancer had similar effectiveness to more frequent, lower dose sessions.
Lilly, AdvanCell to collaborate on alpha treatments for cancer
Eli Lilly (NYSE:LLY) and AdvanCell have agreed to work together on developing alpha therapies for the treatment of cancer.
Pfizer, Astellas Padcev combo shows overall survival benefit in urothelial cancer
A combination of pfizer (NYSE:PFE)and Astellas` (OTCPK:ALPMF) (OTCPK:ALPMY) antibody-drug conjugate Padcev (enfortumab vedotin-rjfv) with Merck`s (MRK) keytruda (pembrolizumab) demonstrated a ustained overall survival and progression-free survival benefit as afirst-line theraphy for urothelial cancer.
UI researchers develop new imaging tool aiming to lower re-operation rates after cancer surgery
The Margin Diagnostics (MarginDx) project combined imaging technology and other tools to assist doctors during surgeries and ensure all tumor cells are removed. The system collects an “optical biopsy,” similar to an ultrasound, but uses light instead.
Advanced cancer treatment coming to Greeneville Community Hospital thanks to $1M from Niswonger family
REENEVILLE, Tenn. (WJHL) — A $1 million donation from Scott Niswonger and his family will bring an advanced cancer treatment center and new technology to the Greeneville Community Hospital.
Middle Schooler Uncovers Surprising Cancer-Fighting Potential in Goose Droppings
When I was still at school, a school trip usually involved a museum or some other such institution. However, a group of school children were recently asked to explore their neighborhood and find potentially beneficial bacteria.
AI could detect cancer in abdomen early, study finds
Artificial intelligence (AI) is becoming an essential tool in medical imaging, helping radiologists analyze scans faster and more accurately. However, AI models need a massive amount of labeled data to work well, which means radiologists still spend a lot of time marking images manually.
Research shows key cause of spread of aggressive prostate cancer
Scientists from MedUni Vienna have made an important discovery that could improve the way aggressive prostate cancer is diagnosed and treated.
Vitamin K Precursor Found to Target and Destroy Cancer Cells in Latest Research
According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives.
Man given pioneering surgery for cancer treatment
A man who dismissed signs of cancer as a mark from his golf bag has become the first patient in the UK to have robotic microsurgery, the Royal Marsden Hospital has claimed.
Mutations in two gene pairs point to a promising drug target in 5% of adult cancers
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have discovered that about 5% of adult cancers rely heavily on a gene called PELO to survive and that disabling the gene kills those cancer cells. These cancers have mutations in one of two genes, FOCAD or TCC37.
Light-activated compound offers hope for overcoming drug resistance in cancer treatment
A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using light. Professors Tae-Hyuk Kwon and Duyoung Min from the Department of Chemistry at UNIST, alongside Professor Taiho Park from POSTECH, have created a photoreactive compound capable of suppressing autophagy in cancer cells—one of the key mechanisms contributing to resistance against anticancer therapies.
Acrivon Therapeutics gets FDA breakthrough device designation for its oncosignature assay for endometrial cancer
Acrivon Therapeutics (NASDAQ:ACRV) announced the U.S. FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay, a multiplex immunofluorescence assay for the identification of endometrial cancer patients who may benefit from ACR-368 treatment.
Geneva researchers discover potential for targeted cancer drug delivery
Researchers in Geneva have determined how some harmful bacteria introduce dangerous enzymes into host cells. They now want to use this discovery to deliver drugs directly to cancer cells.
New Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
Researchers have developed a new nanosystem that provides precision targeting and therapy for tongue cancer, potentially improving treatment outcomes.
